Skip to content

Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture.

Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a 6-grass Pollen Mixture, House Dust Mite (Dermatophagoides Pteronyssinus), Birch Pollen, and Mugwort Pollen

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00665483
Enrollment
Unknown
Registered
2008-04-24
Start date
2007-03-31
Completion date
2010-11-30
Last updated
2013-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type I Allergy

Brief summary

Multicenter Skin Prick Test

Interventions

OTHERSkin Prick Test

Skin Prick Test

Sponsors

Allergopharma GmbH & Co. KG
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* anamnesis referring to suspicion of an IgE-mediated allergy * positive Skin Prick Test in the medical history to at least one of the investigational allergens with an existing anamnesis

Exclusion criteria

* serious chronic diseases * Other perennial allergies

Design outcomes

Primary

MeasureTime frame
Optimal trade-off between sensitivity and specificityDecember 2007 - December 2008

Secondary

MeasureTime frame
Evaluation of the documentation of adverse eventsJanuary - December 2008

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026